Fortress Biotech, Inc. (FBIO) Operating cash flow 2016–2025
Fortress Biotech, Inc. (FBIO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$65.8MFY2025 · since FY2016: -$45.8M → -$65.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$65.8M | +18.0% |
| FY2024 | -$80.2M | +37.5% |
| FY2023 | -$128.2M | +28.5% |
| FY2022 | -$179.4M | -53.9% |
| FY2021 | -$116.5M | -39.3% |
| FY2020 | -$83.7M | +11.9% |
| FY2019 | -$95.0M | +3.9% |
| FY2018 | -$98.8M | -21.6% |
| FY2017 | -$81.3M | -77.5% |
| FY2016 | -$45.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FBIO financial trends
FBIO RevenueFBIO Net incomeFBIO Net marginFBIO Gross profitFBIO Gross marginFBIO Operating incomeFBIO Operating marginFBIO Free cash flowFBIO Capital expendituresFBIO Return on equityFBIO Stock buybacksFBIO Dividends paidFBIO Total assetsFBIO Total liabilitiesFBIO Shareholders’ equityFBIO overview →